Immunohistochemical study of overexpression of fibroblast growth factor-1 (FGF-1), FGF-2, and FGF receptor-1 in human malignant salivary gland tumours

Journal of Pathology

Volumn 178, Issue 4, 1996, Pages 429-436

  Myoken, Yoshiko ^a   Myoken, Yoshinari ^b   Okamoto, Tetsuji ^a   Sato, J Denry ^c   Kan, Mikio ^d   Mckeehan, Wallace L ^d   Nakahara, Mitsuru ^e   Takada, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Hiroshima Red Cross Atom Bomb SH ^*  (Japan)

^c Adirondack Biomedical Research Institute Inc   (United States)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^e HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Fibroblast growth factor; Fibroblast growth factor receptor; Immunohistochemistry; Malignant salivary gland tumour

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR;

ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; SALIVARY GLAND CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOID CYSTIC; CARCINOMA, MUCOEPIDERMOID; FEMALE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PAROTID GLAND; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; SALIVARY GLAND NEOPLASMS; SUBMANDIBULAR GLAND;

EID: 0029867434     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199604)178:4<429::AID-PATH495>3.0.CO;2-1     Document Type: Article

References (30)

1. Seifert G. World Health Organization (WHO) International Histological Classification of Tumors Histological Typing of Salivary Gland Tumors. 2nd edn. Berlin: Springer-Verlag, 1991.
2. Press MF, Pike MC, Hung G, et al. Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland- correlation with poor prognosis. Cancer Res 1994; 54: 5675-5682
3. Kurokawa R, Kyakumoto S, Ota M. Autocrine growth factor in defined serum-free medium of human salivary gland adenocarcinoma cell line HSG. Cancer Res 1989; 49: 5136-5142
4. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Anna Rev Biochem 1989, 58: 575-606.
5. Tanaka A, Miyamoto K, Minamino N. et al. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc Natl Acad Sci USA 1992; 89: 8928-8932.
6. Miyamoto M, Naruo K, Seko C, Matsumoto S, Kondo T, Kurokawa T. Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol Cell Biol 1993; 13: 4251-4259.
7. D'Amore PA. Modes of FGF release in vivo and in vitro. Cancer Metastasis Rev 1990; 9: 227-238.
8. Givol D, Yayon A Complexity of FGF receptors; genetic basis for structural diversity and functional specificity. FASEB J 1992; 6: 3362-3369
9. Johnsos DE, Williams LT. Structural and functional diversity of the FGF receptor multigene family Adv Cancer Res 1993; 60: 1-41.
10. Dionne CA, Crumley G, Bellot F, et al. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J 1990; 9: 2685-2692.
11. Stefanik DF, Rizkalla LR, Soi A, Goldblatt SA, Rizkalla WM Acidic and basic fibroblast growth factors are present in gltoblastoma multiforme. Cancer Res 1991, 51: 5760-5765.
12. Zagzag D, Miller DC, Sato Y, Rifkin DB, Burstein DE Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res 1990; 50: 7393-7398
13. Yamanaka Y, Friess H, Buchler M, et al. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993; 53: 5289-5296.
14. Myoken Y, Myoken Y, Okamoto T, et al. Immunocytochemical localization of fibroblast growth factor-1 (FGF-1) and FOF-2 in oral squamous cell carcinoma J Oral Pathol Med 1994; 23: 451-156.
15. Tanimoto H, Yoshida K, Yokozaki H, et al Expression of basic fibroblast growth factor in human gastric carcinomas. Virchows Arch B [Cell Pathol] 1991; 61: 263-267.
16. Eguchi J, Nomata K, Kanda S, et al. Gene expression and immunohistochemical localization of basic fibroblast growth factor in renal cell carcinoma Biochem Biophys Res Commun 1992; 183: 937-944.
17. Morrison RS, Yamaguchi F, Bruner JM. Tang M, McKeehan WL. Berger MS. Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme. Cancer Res 1994; 54: 2794-2799.
18. Kobrin MS, Yamanaka Y, Friess H, Lopez ME, Korc M. Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res 1993; 53: 4741-4744.
19. Morrison RS. Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J Biol Chem 1991; 266: 728-734
20. Myoken Y, Myoken Y, Okamoto T, Kan M, Sato JD, Takada K Release of fibroblast growth factor-1 by human squamous cell carcinoma correlates with autocrine cell growth In Vitro Cell Dev Biol 1994; 30: 790-795
21. Jaye M, Lyall RM, Mudd R, Schlessinger J, Sarver N. Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumongenesis to Swiss 3T3 cells. EMBO J 1988; 7: 963-969.
22. Sasada R, Kurokawa T, Iwane M, Igarashi K. Transformation of mouse BALB/c 3T3 cells with human basic fibroblast growth factor cDNA Mol Cell Biol 1988; 8: 588-594.
23. Myoken Y, Kan M, Chen J, McKeehan WL, Sato OH, Sato JD. Monoclonal antibodies against heparin-binding growth factor (HBOF-1): neutralization of biological activity and recognition of specific amino acid sequence. Biochem Biophys Res Commun 1993; 197: 1450-1457.
24. Matsuzaki K, Yoshitake Y, Matuo Y, Sasaki H, Nishikawa K, Monoclonal antibodies against heparin-binding growth factor-II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc Natl Acad Sci USA 1989, 86: 9911-9915
25. Xu J, Nakahara M, Crabb JW, et al Expression and immunochemical analysis of rat and human fibroblast growth factor receptor (fig) informs. J Biol Chem 1992, 267: 17792-17803.
26. Hsu SM, Raine L, Fanger H. Use of avidin-biotm-peroxidase complex fABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580.
27. Sporn MB, Roberts AB. Autocrine growth factors and cancer. Nature 1985. 313: 745-747.
28. Sano H, Forough R, Maier JAM. et al. Detection of high levels of heparin binding growth factor-] (acidic fibroblast growth factor) in inflammatory arthritis joints, J Cell Biol 1990; 110: 1417-1426.
29. Zhan X, Hu X, Friedman S, Maciag T Analysis of endogenous and exogenous nuclear translocation of fibroblasl growth factor-1 in NIH 3T3 cells. Biochem Biophys Res Commun 1992; 188: 982-991.
30. Baldin V, Roman AM, Bosc-Bierne I, Amalric F, Bouche G. Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothehal cells EMBO J 1990; 9: 1511-1517